Dessert Vendor Show at UC Irvine
Come join us at the UC Irvine Medical School for our Dessert Vendor Show!
Learn about the highest quality DNA Sequencing from Eton Bioscience Inc. and see products from several other vendors. Dessert will be on us!
Houston Branch Closing.
The Houston Branch is closing, and we would like to thank all of our wonderful employees and customers that we truly enjoyed getting to know these past five months.
If any of our customers wants to continue sending out to us they can FedEx to us.
Otherwise they can begin to look for another sequencing provider.
Save the date! 19th Annual Texas Protein Folders March 25-27, 2011
Save the date! We are sponsoring the 19th annual Texas Protein Folders Meeting next year and we couldn’t be more excited about it.
Registration deadline March 18th 2011
Keynote Speakers:
Joshua Wand, University of Pennsylvania School of Medicine
The Wand lab probes the relationships between protein structure, dynamics, and function, often relying on novel NMR methods developed in house, such as high pressure NMR, sparse sampling methods, NMR relaxation methods, and developing approaches to investigate large soluble proteins, unstable proteins, and membrane proteins by liquid NMR methods.
Vijay Pande, Stanford University,
The Pande lab uses physical simulation and Bayesian statistics / machine learning techniques to investigate protein folding at long time scales with the goal of predicting all possible experimental observables. In related projects, the Pande lab uses computational tools to probe the structure and stability of misfolded protein aggregates and small molecule binding / drug efficacy.
The meeting is chaired this year by Dr. Sarah Bondos from Texas A&M University.
If you are in the world of proteins and live in Texas, it is certainly the meeting for you.
Sanford Burnham Medical Research Institute at Lake Nona from 1130-1 pm on June 8
We have an upcoming show in the Sanford Burnham Medical Research Institute at Lake Nona on June 8 from 1130-1 pm. We will be serving food and have a lot of new products and services to unleash. For those who want to try out our new Bluefast protein staining solution we will be able to sign people up for a free trial bottle. We also will have some fun specials for the show only that will be for DNA Sequencing and our peptides, so be there to get great deals.
A full list of attendees are:
Applied Biosystems part of Life Technologies
AnaSpec Inc
Bartlett-Williams Scientific Resources
Caron Products
Cell Signaling Technology
Florida Pipette Calibrations
GenVault Corporation
Gilson Inc
Harvard Apparatus
Heidolph Brinkmann LLC
The Jackson Laboratory
Lifeline Cell Technologies
LONZA
Mediatech Inc
Meso Scale Discovery
Molecular Devices now part of Danaher Corporation
Olympus America Inc
Eurofins Operon
PerkinElmer
SeraCare Life Sciences
SP Industries
VisEn Medical Inc
Wheaton Science Products
Hope to see you there!
Univ of Florida Gainesville Show on 6/9 from 1130-1 pm
We have an upcoming show in the McKnight Brain building MBI on June 9 from 1130-1 pm. We will be serving food and have a lot of new products and services to unleash. For those who want to try out our new Bluefast protein staining solution we will be able to sign people up for a free trial bottle. We also will have some fun specials for the show only that will be for DNA Sequencing and our peptides, so be there to get great deals.
A full list of the vendors attending are:
Florida Pipette Calibrations
GenVault Corporation
Gilson Inc
Heidolph Brinkmann LLC
The Jackson Laboratory
Lifeline Cell Technologies
Mediatech Inc
Molecular Devices now part of Danaher Corporation
Phenix Research Products
Rainin Instrument LLC
SeraCare Life Sciences
SP Industries
Wheaton Science Products
We really hope to see you there!
Show at Texas A&M on May 26th from 11:30-1:30
We really hope that you are able to join us for Rudy’s BBQ and to talk more about the changes happening to our DNA Sequencing Services in the college station area. We are planning on adding a free pick up service and free shipping to all of our customers at TAMU and the biotechs that are close-by.
We are hiring an undergraduate or recent graduate to pick up samples for us. If you know of a good student, then please tell them to email holly@etonbio.com with their resume or cover letter.
If you want to know all of the companies that are coming to the show then please check out the link below.
We also are releasing some new human protein kinases that are expressed in mammalian cells.
Come see us for all the exciting new information!
March Sequencing Madness
Our North Carolina DNA Sequencing branch has gone completely mad for DNA Sequencing. Any new customers in the eastern region of the US that sign up for DNA Sequencing during March Madness will receive *free DNA Sequencing* throughout the duration of March Madness with a certain amount that they will receive each day. The only way to find out what you
qualify for is to contact Richard at richard@etonbio.com or call him at (919)314-5539.
We haven’t forgotten our regular customers though, and we have special surprises for them, so if you are one of our regulars in the eastern region, contact Richard and see what special surprises he can get for you.
IBT Product Show on March 22nd From 12-1:30
Come for the products and stay for the food. IDT, the top quality oligo synthesis provider is doing a product show with us this week in IBT in the Houston Medical Center. We will be showcasing our local DNA Sequencing service and giving out free trial cards to new users that have never had the opportunity to see our convenience. Rumor has is that IDT may be bringing Oligo cards, as well.
The show will be on March 22nd from 12-130 pm on the 11th floor.
We will be serving pizza for lunch and giving away some fun Easter treats for attendees.
The NC CED Conference Biotech Show from Feb 22-23rd
CED’s Biotech 2010 was held at the Raleigh Convention Center on February 22 and 23. According to the opening remarks of Joan Siefert Rose, President of CED, the conference boasted the largest collection of venture capitalists ever collected in North Carolina.
The conference focused on the business of biotech, with special attention paid to mergers, partnering, and all other ways to find funding. The major topic of discussion was adapting to the current economic environment. With the United States economy continuing to show no major signs of improvement, funding for research and development is more difficult to find. In addition, the development of biotechnologies and the possibility of health care reform in Washington are giving non-traditional business models more of a chance to come to the forefront, creating more uncertainty for investors.
For example, many panelists indicated that they felt the era of the “blockbuster” pharmaceutical drug was over. The idea is that personalized medicine will offer a new business model with a focus on drugs with a smaller, better specified target population. Research in biomarkers is expected to lead to continuously improved diagnostics and the possibility of combining diagnostics with therapeutics in ways not possible before.
The role of the initial public stock offering (IPO) in the panels also indicated a new era in financing. In today’s economic environment, the IPO, according to most panelists, is no longer a good option for most private start-ups. RTP’s own Talecris received kudos for being the most (and possibly only, depending on who you ask) successful IPO of the last year in the biotech industry. With the stock market and venture capital looking for safer investments, most panelists found biotech companies looking for increasingly more “non-dilutive” capital, which includes corporate partnerships/alliances, government funding, and grants.
The highlight of the conference for many attendees was a powerful speech given by Billy Tauzin, President and CEO of Pharmaceuticals Research and Manufacturers of America (PhRMA). Tauzin served Louisiana’s third district in Congress for 25 years – from 1980-1995 as a Democrat and from 1995-2005 as a Republican. Discussing the current political environment, Tauzin bemoaned the current state of hyper-partisanship. He warned against the use of reconciliation or the so-called “nuclear option” for passage of health care reform in the Senate, feeling that the use of either could only make the partisan political environment worse and hurt both political parties in the future.
Mixed in with Tauzin’s highly relevant political observations was a highly personal story about his own battle with cancer. He thanked the members of the audience for their work and warned against another type of partisanship within the science community. In the middle of a conference that mixed large pharmaceutical companies and small biotech start-ups, he emphasized that it is all one industry and encouraged the attendees not to separate the interests of PhRMA from biotech in general.






